November 20, 2018 12:00 pm
MMRF Tribute Page - Creating one is a wonderful way to honor your, or a loved one’s, journey while supporting the MMRF’s mission towards a cure. Share your story and give others a chance to show their support of critical research.
November 16, 2018 10:45 am
November 11, 2018 10:45 am
November 8, 2018 12:00 pm
(New England Journal of Medicine)
The immunostimulatory monoclonal antibody elotuzumab plus lenalidomide and dexamethasone has been shown to be effective in patients with relapsed or refractory multiple myeloma. The...